Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

AORT

Artivion Inc

Apr 24 • 04:00PM ET

20.92

Dollar change +0.14
Percentage change 0.67	%

Healthcare • Medical Devices • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI IWM VXF IWN IHI IJS IJT SCHA VIOO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.75	Insider Own	6.20%	Shs Outstand	41.08M	Perf Week	4.91%
Market Cap	872.57M	Forward P/E	205.10	EPS next Y	0.10	Insider Trans	-8.09%	Shs Float	39.12M	Perf Month	4.50%
Income	-30.56M	PEG	-	EPS next Q	-0.12	Inst Own	87.07%	Short Float	7.16%	Perf Quarter	23.86%
Sales	354.00M	P/S	2.46	EPS this Y	60.80%	Inst Trans	4.30%	Short Ratio	12.60	Perf Half Y	56.70%
Book/sh	6.86	P/B	3.05	EPS next Y	134.69%	ROA	-3.93%	Short Interest	2.80M	Perf Year	48.69%
Cash/sh	1.41	P/C	14.80	EPS next 5Y	2.00%	ROE	-10.80%	52W Range	12.16 - 21.90	Perf YTD	17.00%
Dividend Est.	-	P/FCF	78.26	EPS past 5Y	-57.58%	ROI	-4.82%	52W High	-4.47%	Beta	1.65
Dividend TTM	-	Quick Ratio	2.57	Sales past 5Y	6.52%	Gross Margin	60.33%	52W Low	72.06%	ATR (14)	0.63
Dividend Ex-Date	Dec 09, 2015	Current Ratio	3.99	EPS Y/Y TTM	-57.61%	Oper. Margin	1.51%	RSI (14)	55.31	Volatility	3.03% 2.95%
Employees	1500	Debt/Eq	1.28	Sales Y/Y TTM	12.82%	Profit Margin	-8.63%	Recom	1.00	Target Price	25.15
Option/Short	Yes / Yes	LT Debt/Eq	1.25	EPS Q/Q	-281.61%	Payout	-	Rel Volume	0.78	Prev Close	20.78
Sales Surprise	4.92%	EPS Surprise	-16.28%	Sales Q/Q	17.98%	Earnings	Feb 15 AMC	Avg Volume	222.40K	Price	20.92
SMA20	0.13%	SMA50	4.49%	SMA200	22.11%	Trades		Volume	172,977	Change	0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-27-22	Reiterated	Lake Street	Buy	$32 → $28
Aug-08-22	Initiated	Lake Street	Buy	$32
Mar-03-22	Initiated	Stifel	Buy	$30

Apr-22-24 04:10PM	Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results (PR Newswire)
Apr-15-24 09:40AM	Is Artivion (AORT) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-01-24 04:10PM	Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-29-24 09:15AM	Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run? (Zacks)
Mar-28-24 09:40AM	Are Medical Stocks Lagging Artivion (AORT) This Year? (Zacks)
09:40AM	Loading…
Mar-12-24 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-06-24 04:10PM	Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference (PR Newswire)
Feb-22-24 09:40AM	Is Artivion (AORT) Outperforming Other Medical Stocks This Year? (Zacks)
09:15AM	Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? (Zacks)
Feb-21-24 09:55AM	Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet (Zacks)
Feb-16-24 10:39AM	Artivion, Inc. (NYSE:AORT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-15-24 04:05PM	Artivion Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-01-24 04:10PM	Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Jan-29-24 08:25AM	Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting (PR Newswire)
Jan-18-24 04:05PM	Artivion Obtains $350 Million in Senior Secured Credit Facilities (PR Newswire)
04:15PM	Loading…
Dec-06-23 04:15PM	Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer (PR Newswire)
Nov-09-23 08:25AM	Artivion Announces Completion of Enrollment in PERSEVERE Trial (PR Newswire)
Nov-08-23 04:05PM	Artivion to Participate in Upcoming Investor Conferences (PR Newswire)
Nov-02-23 04:05PM	Artivion Reports Third Quarter 2023 Financial Results (PR Newswire)
Oct-19-23 04:10PM	Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results (PR Newswire)
Oct-05-23 04:15PM	Artivion Announces Presentation of Real World Data from Post Market Study of On-X Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin (PR Newswire)
04:05PM	Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting (PR Newswire)
Sep-26-23 08:25AM	Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference (PR Newswire)
Sep-14-23 08:05AM	Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase (PR Newswire)
Aug-31-23 09:55AM	Wall Street Analysts Believe Artivion (AORT) Could Rally 44.41%: Here's is How to Trade (Zacks)
Aug-10-23 09:55AM	Does Artivion (AORT) Have the Potential to Rally 52.78% as Wall Street Analysts Expect? (Zacks)
Aug-03-23 04:05PM	Artivion Reports Second Quarter 2023 Financial Results (PR Newswire)
Aug-01-23 08:25AM	Artivion to Participate in Upcoming Investor Conferences (PR Newswire)
Jul-20-23 08:25AM	Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results (PR Newswire)
Jun-21-23 08:00PM	AORT: What does Argus have to say about AORT? (Argus Research)
08:04AM	Loading…
May-23-23 08:04AM	Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter (PR Newswire)
May-04-23 04:05PM	Artivion Reports First Quarter 2023 Financial Results (PR Newswire)
Apr-26-23 08:00PM	AORT: What does Argus have to say about AORT? (Argus Research)
Apr-20-23 04:10PM	Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results (PR Newswire)
Apr-10-23 04:10PM	Artivion to Participate in the 22nd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-06-23 04:10PM	Artivion to Participate in the Oppenheimer 33rd Annual Healthcare Conference (PR Newswire) -7.10%
Feb-16-23 04:05PM	Artivion Reports Fourth Quarter and Full Year 2022 Financial Results (PR Newswire)
Feb-02-23 08:30AM	Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) +7.46%
Nov-25-22 12:00PM	Artivion (AORT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	Wall Street Analysts Think Artivion (AORT) Could Surge 79%: Read This Before Placing a Bet (Zacks)
Nov-09-22 09:55AM	Wall Street Analysts Predict a 173% Upside in Artivion (AORT): Here's What You Should Know (Zacks)
Nov-08-22 04:25PM	Artivion to Participate in Upcoming Investor Conferences (PR Newswire)
Nov-03-22 04:05PM	Artivion Reports Third Quarter 2022 Financial Results (PR Newswire)
Oct-20-22 08:25AM	Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2022 Financial Results (PR Newswire)
Sep-29-22 04:10PM	Elizabeth Hoff Joins Artivion Board of Directors (PR Newswire)
Sep-23-22 07:00AM	Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial (PR Newswire) -28.05%
Sep-14-22 08:10AM	Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference (PR Newswire)
Sep-06-22 04:10PM	Artivion to Participate in Upcoming Investor Conferences (PR Newswire)
Aug-24-22 04:10PM	Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase (PR Newswire)
Aug-04-22 04:05PM	Artivion Reports Second Quarter 2022 Financial Results (PR Newswire)
Aug-03-22 08:25AM	Artivion to Participate in Upcoming Investor Conferences (PR Newswire)
Jul-29-22 12:00PM	What Makes Artivion (AORT) a New Buy Stock (Zacks)
Jul-27-22 08:25AM	Artivion Initiates Enrollment in PERSEVERE Clinical Trial (PR Newswire)
Jul-21-22 08:25AM	Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results (PR Newswire)
May-16-22 08:25AM	Artivion to Participate in the UBS 2022 Global Healthcare Conference (PR Newswire) +5.06%
May-12-22 02:55PM	Further weakness as Artivion (NYSE:AORT) drops 24% this week, taking three-year losses to 48% (Simply Wall St.)
May-05-22 04:05PM	Artivion Reports First Quarter 2022 Financial Results (PR Newswire) -7.44%
Apr-21-22 08:25AM	ArtivionAnnounces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results (PR Newswire)
Mar-31-22 08:25AM	Artivion to Participate in the 21st Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-27-22 02:33PM	Are Institutions Heavily Invested In Artivion, Inc.'s (NYSE:AORT) Shares? (Simply Wall St.)
Mar-14-22 04:10PM	Artivion Publishes Inaugural Corporate Responsibility Report (PR Newswire)
Mar-10-22 12:48PM	Thermo Fisher Scientific (Finance I) B.V. -- Moody's announces completion of a periodic review for a group of North America Medical Products and Device issuers (Moody's)
12:17PM	Danaher Corporation -- Moody's announces completion of a periodic review for a group of North America Medical Products and Device issuers (Moody's)
Mar-09-22 08:15AM	Artivion to Host Investor & Analyst Day on March 23, 2022 (PR Newswire)
Mar-03-22 04:05PM	Artivion to Participate in the Oppenheimer 32nd Annual Healthcare Conference (PR Newswire)
Feb-17-22 04:05PM	Artivion Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
Feb-03-22 08:05AM	Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
Jan-31-22 08:05AM	Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery (PR Newswire)

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stanton Marshall S.	SVP, Clinical & MD Affair	Mar 20 '24	Sale	20.39	2,183	44,511	83,296	Mar 21 05:14 PM
GREEN ANDREW M	VP Regulatory	Mar 15 '24	Sale	20.00	1,462	29,240	41,121	Mar 18 06:09 PM
GREEN ANDREW M	VP Regulatory	Mar 14 '24	Sale	20.00	3,994	79,880	42,583	Mar 15 05:20 PM
Getz Matthew A	VP, Human Resources	Mar 12 '24	Sale	19.94	5,000	99,720	43,536	Mar 14 09:06 PM
Mackin James P	President & CEO	Mar 05 '24	Sale	18.72	13,996	262,037	705,562	Mar 07 06:20 PM
Holloway Jean F	SVP, General Counsel	Mar 05 '24	Sale	18.72	2,380	44,559	169,669	Mar 07 06:16 PM
Davis John E	Chief Commercial Officer	Mar 05 '24	Sale	18.72	2,022	37,856	165,637	Mar 07 06:14 PM
Stanton Marshall S.	SVP, Clinical & MD Affair	Mar 05 '24	Sale	18.72	1,506	28,195	85,438	Mar 07 06:05 PM
GREEN ANDREW M	VP Regulatory	Mar 05 '24	Sale	18.72	1,160	21,718	46,541	Mar 07 06:07 PM
Maney Rochelle L.	VP, Quality	Mar 05 '24	Sale	18.72	1,157	21,662	46,536	Mar 07 06:10 PM
Getz Matthew A	VP, Human Resources	Mar 05 '24	Sale	18.72	1,157	21,661	48,503	Mar 07 06:12 PM
Horton Amy	VP, Chief Accounting Officer	Mar 05 '24	Sale	18.72	1,152	21,568	139,957	Mar 07 06:01 PM
Mackin James P	President & CEO	Feb 27 '24	Sale	19.83	4,837	95,939	690,940	Feb 29 05:36 PM
Davis John E	Chief Commercial Officer	Feb 27 '24	Sale	19.83	584	11,583	161,935	Feb 29 05:32 PM
Holloway Jean F	SVP, General Counsel	Feb 27 '24	Sale	19.83	485	9,620	166,325	Feb 29 05:34 PM
Stanton Marshall S.	SVP, Clinical & MD Affair	Feb 27 '24	Sale	19.83	465	9,223	81,220	Feb 29 05:18 PM
GREEN ANDREW M	VP Regulatory	Feb 27 '24	Sale	19.83	421	8,350	44,123	Feb 29 05:21 PM
Maney Rochelle L.	VP, Quality	Feb 27 '24	Sale	19.83	370	7,339	44,115	Feb 29 05:30 PM
Tyrs Florian	VP, Global Operations	Feb 27 '24	Sale	19.83	339	6,724	21,558	Feb 29 05:43 PM
Horton Amy	VP, Chief Accounting Officer	Feb 27 '24	Sale	19.83	325	6,446	137,531	Feb 29 05:39 PM
Getz Matthew A	VP, Human Resources	Feb 27 '24	Sale	19.83	325	6,446	46,082	Feb 29 05:27 PM
Mackin James P	President & CEO	Feb 26 '24	Sale	20.27	31,312	634,729	650,297	Feb 28 05:22 PM
Davis John E	Chief Commercial Officer	Feb 26 '24	Sale	20.27	3,514	71,233	151,687	Feb 28 05:12 PM
Stanton Marshall S.	SVP, Clinical & MD Affair	Feb 26 '24	Sale	20.27	3,048	61,786	72,489	Feb 28 05:01 PM
Holloway Jean F	SVP, General Counsel	Feb 26 '24	Sale	20.27	2,880	58,381	155,540	Feb 28 05:18 PM
GREEN ANDREW M	VP Regulatory	Feb 26 '24	Sale	20.27	2,403	48,711	38,848	Feb 28 05:04 PM
Maney Rochelle L.	VP, Quality	Feb 26 '24	Sale	20.27	2,315	46,928	39,197	Feb 28 05:16 PM
Getz Matthew A	VP, Human Resources	Feb 26 '24	Sale	20.27	2,313	46,887	40,123	Feb 28 05:07 PM
Tyrs Florian	VP, Global Operations	Feb 26 '24	Sale	20.27	893	18,103	21,897	Feb 28 04:58 PM
Mackin James P	President & CEO	Feb 20 '24	Option Exercise	16.30	59,225	965,368	611,105	Feb 22 05:08 PM
Mackin James P	President & CEO	Feb 20 '24	Sale	18.85	72,069	1,358,818	539,036	Feb 22 05:08 PM
Holloway Jean F	SVP, General Counsel	Feb 20 '24	Sale	18.86	3,527	66,537	131,858	Feb 22 05:37 PM
Davis John E	Chief Commercial Officer	Feb 20 '24	Sale	18.86	2,556	48,219	128,177	Feb 22 05:32 PM
Horton Amy	VP, Chief Accounting Officer	Feb 20 '24	Sale	18.86	1,695	31,976	122,345	Feb 22 05:35 PM
Getz Matthew A	VP, Human Resources	Feb 20 '24	Sale	18.86	1,695	31,976	28,692	Feb 22 05:26 PM
Maney Rochelle L.	VP, Quality	Feb 20 '24	Sale	18.86	407	7,678	29,123	Feb 22 05:29 PM
Tyrs Florian	VP, Global Operations	Feb 20 '24	Sale	18.86	249	4,697	16,253	Feb 22 05:22 PM
Holloway Jean F	SVP, General Counsel	Jan 02 '24	Option Exercise	16.30	21,229	346,033	154,749	Jan 04 04:25 PM
Davis John E	Senior VP, Global Sales	Jan 02 '24	Option Exercise	16.30	13,562	221,061	142,295	Jan 04 04:22 PM
Holloway Jean F	SVP, General Counsel	Jan 02 '24	Sale	18.00	21,229	382,122	133,520	Jan 04 04:25 PM
Davis John E	Senior VP, Global Sales	Jan 02 '24	Sale	18.00	13,562	244,116	128,733	Jan 04 04:22 PM
Horton Amy	VP, Chief Accounting Officer	Dec 15 '23	Option Exercise	16.30	14,397	234,671	138,437	Dec 19 05:23 PM
Horton Amy	VP, Chief Accounting Officer	Dec 15 '23	Sale	19.00	14,397	273,543	124,040	Dec 19 05:23 PM
Horton Amy	VP, Chief Accounting Officer	Nov 27 '23	Sale	17.34	2,101	36,431	105,599	Nov 29 09:15 AM
Getz Matthew A	VP, Human Resources	Jun 07 '23	Sale	15.88	6,329	100,483	30,387	Jun 08 05:20 PM
Maier Dennis B	SVP, Operations	Jun 06 '23	Sale	15.27	16,254	248,163	34,724	Jun 08 05:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AORT

Artivion Inc

Upgrade your FINVIZ experience